Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312492 · ClinicalTrials.gov registry record · NA
Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans
A NA study of Dyslipidemia, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02312492 is a NA study of Dyslipidemia that has completed, run by Tufts University. The registered enrollment target is 6 participants, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02312492, a NA study of Dyslipidemia, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Specific Aim 1: To compare the metabolic fate (transport, conversion and oxidation) of labeled 18:0 (13C18:0) and its metabolic product 18:1 (13C18:1) in the fed state after habituation to diets enriched in the corresponding fatty acid. Hypothesis: In the fed state, the metabolic fate of 13C18:0 compared to 13C18:1 will be characterized by similar transport, higher conversion, and similar oxidation rates..
Conditions Studied
Interventions
- OTHER Oleic Diet
- OTHER Palmitic Diet
- OTHER Stearic Diet
Study Locations (1)
Massachusetts
- Jean Mayer Human Nutrition Research Center on Aging - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02312492
The ClinicalTrials.gov registry entry for NCT02312492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (98% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 3 interventions - of which Oleic Diet is the first listed.
NCT02312492 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02312492 about?
NCT02312492 is a clinical study titled "Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans". Specific Aim 1: To compare the metabolic fate (transport, conversion and oxidation) of labeled 18:0 (13C18:0) and its metabolic product 18:1 (13C18:1) in the fed state after habituation to diets enriched in the corresponding fatty acid. Hypothesis: In the fed state, the metabolic fate of 13C18:0 co...
What is the current status of trial NCT02312492?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2018-12.
What conditions does trial NCT02312492 study?
This clinical trial studies the following conditions: Dyslipidemia.
What interventions are being tested in trial NCT02312492?
The interventions under investigation include: Oleic Diet (OTHER), Palmitic Diet (OTHER), Stearic Diet (OTHER).
Who is sponsoring clinical trial NCT02312492?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02312492 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyslipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Intermittent Cottonseed Oil Consumption
RECRUITING · NA
-
Change of Fructose to Fat in South Asians
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.